Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
- None.
- None.
NEW YORK, March 06, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will participate in three upcoming investor conferences:
Leerink Partners Global Biopharma Conference
Tuesday, March 12, 2024 at 10:40 a.m. ET in Miami, FL
Jefferies Biotech on the Bay Summit
Wednesday, March 13, 2024 in Miami, FL
UBS Virtual CNS Day
Monday, March 18, 2024
A live and achieved webcast of the Company’s presentation at the Leerink Partners Global Biopharma Conference can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.
About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.
Contact:
Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333
Burns McClellan, Inc.
Cameron Radinovic
cradinovic@burnsmc.com
212-213-0006
FAQ
When will Intra-Cellular Therapies participate in the Leerink Partners Global Biopharma Conference?
What is the focus of Intra-Cellular Therapies?
Where can investors access the webcast of Intra-Cellular Therapies' presentation at the Leerink Partners Global Biopharma Conference?
